PT  - JOURNAL ARTICLE
AU  - Li, Yuebing
AU  - Arora, Yeeshu
AU  - Levin, Kerry
TI  - Myasthenia gravis: Newer therapies offer sustained improvement
AID  - 10.3949/ccjm.80a.13044
DP  - 2013 Nov 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 711--721
VI  - 80
IP  - 11
4099  - http://www.ccjm.org/content/80/11/711.short
4100  - http://www.ccjm.org/content/80/11/711.full
SO  - Cleve Clin J Med2013 Nov 01; 80
AB  - Myasthenia gravis is a prototypical antibody-mediated autoimmune neuromuscular disorder. Treatments have improved over the past 30 years, leading to significantly fewer deaths and better quality of life. Future research should further elucidate its pathogenesis, reveal better ways to diagnose it, and yield new treatments.